

Is Briviact in shortage in 2026? Get the latest update on brivaracetam availability, why it's hard to find, and how to get your prescription filled.
If you've been having trouble filling your Briviact (brivaracetam) prescription, you're probably wondering: is there an actual shortage? The answer is nuanced — and important to understand so you can take the right steps.
Let's break down exactly what's happening with Briviact availability in 2026, why you might be struggling to find it, and what you can do about it.
As of March 2026, Briviact is not listed in an official FDA drug shortage. The FDA maintains a public database of medications experiencing supply disruptions, and brivaracetam does not appear on it.
However, that doesn't mean it's easy to find. There's a difference between a formal drug shortage (where manufacturing or supply chain issues limit nationwide availability) and a findability problem (where the medication exists but isn't widely stocked at retail pharmacies). Briviact falls firmly in the second category.
We rate Briviact's findability at 55 out of 100 — meaning patients face moderate difficulty locating it at their usual pharmacy. It's not impossible to find, but you may need to look beyond your regular chain pharmacy.
Several factors make Briviact harder to locate than common medications:
Briviact is a specialty anti-epileptic prescribed primarily by neurologists. Chain pharmacies like CVS, Walgreens, and Rite Aid stock medications based on demand volume. If a location only fills a few Briviact prescriptions per month — or none — it won't keep the medication on hand.
While Lupin received FDA approval for a generic brivaracetam oral solution in February 2026, generic tablets have not yet launched broadly in the U.S. This means most patients are still filling brand-name Briviact, which has a higher cost and lower distribution footprint.
Briviact is classified as a DEA Schedule V controlled substance. While this is the lowest level of controlled scheduling, it still adds ordering, storage, and reporting requirements that some pharmacies prefer to avoid for low-volume medications.
UCB distributes Briviact through specific wholesaler networks. Not every retail pharmacy has equal access to every wholesaler's catalog, which can create local availability gaps even when the national supply is adequate.
Cost is often intertwined with availability — and for Briviact, it's significant:
If cost is a barrier, we have a detailed guide on how to save money on Briviact that covers savings cards, patient assistance programs, and discount strategies.
The biggest development in 2026 is Lupin's FDA approval of generic brivaracetam oral solution (10 mg/mL) in February 2026. While this isn't a tablet formulation (which is what most patients take), it represents the beginning of generic competition for brivaracetam. More generic approvals — including tablets — are expected to follow.
More specialty pharmacy networks are recognizing the demand for epilepsy medications and expanding their formularies. If your insurance plan has a specialty pharmacy option, it's worth checking whether they carry Briviact.
Here are practical steps you can take today:
For more detailed strategies, see our complete guide on how to find Briviact in stock near you.
If you've exhausted your options and genuinely cannot find Briviact, talk to your neurologist about alternatives. Medications like Levetiracetam (Keppra), Lacosamide (Vimpat), and Perampanel (Fycompa) are potential substitutes — though each has different benefits and trade-offs.
Never stop taking Briviact abruptly. Sudden discontinuation of anti-seizure medications can trigger withdrawal seizures, including potentially dangerous seizure clusters or status epilepticus. If you're running low, treat it as urgent and contact your neurologist right away.
Briviact is not in a formal shortage in 2026, but real-world availability remains challenging for many patients. The specialty nature of the medication, lack of generic tablets, controlled substance requirements, and limited retail stocking all contribute to the problem.
The situation is slowly improving — generic brivaracetam is beginning to enter the market, and awareness of the availability issue is growing among pharmacies and healthcare providers. In the meantime, tools like Medfinder, independent pharmacies, and proactive refill planning are your best strategies for staying supplied.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.